Phase 1 SARS CoV-2 Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Systemic Inflammatory Response SyndromeSARS CoV-2Respiratory distress syndrome+2 more

PEACHES BIOTECH50 enrolled3 locationsNCT06684379

Recruiting

Phase 1

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

Long COVIDSARS CoV-2Neurodegeneration+1 more

Stephanie B. Seminara, MD40 enrolled1 locationNCT07224490

Recruiting

Phase 1

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

COVID-19SARS CoV-2

Rokote Laboratories Finland Oy20 enrolled1 locationNCT07416539